Short-chain fatty acids — butyrate, acetate, and propionate — are the most anti-inflammatory chemicals the human body produces. They are made by gut bacteria from dietary fibre, and they are the biochemical mechanism connecting what you eat to your gut barrier integrity, your gut nerve sensitivity, your immune calibration, and your mood. This is their story.
📅 March 2026 · ⏱️ 17 min read · 🔬 Science-backed · Category: Gut Microbiome Science · Part of the Gut Microbiome Guide
Short-chain fatty acids (SCFAs) are small molecules — primarily butyrate, acetate, and propionate — produced when gut bacteria ferment dietary fibre in the large intestine. They are the most important output of the gut microbiome for human health. Butyrate is the primary energy source for the cells lining the colon, the key molecule repairing and maintaining the gut barrier, and the natural mechanism that soothes overreactive gut nerve endings (visceral hypersensitivity). Acetate and propionate reach the liver and bloodstream, influencing energy metabolism, appetite regulation, and systemic immune calibration. When fibre intake is low and the gut microbiome is depleted — as in the vast majority of people with IBS — SCFA production falls, the gut barrier weakens, the immune system over-activates, and gut nerves become chronically sensitised. Restoring SCFA production through dietary fibre diversity and microbiome rebuilding is the central biological mechanism of gut health recovery.
Short-chain fatty acids are organic acids with carbon chains of two to six atoms — “short” in chemistry terms because longer-chain fatty acids (like those in dietary fat) have twelve or more carbons. Despite their small molecular size, they have outsized biological effects — functioning simultaneously as an energy source, a signalling molecule, an anti-inflammatory compound, a barrier repair agent, and a neuroactive chemical.
They are produced exclusively through microbial fermentation. Human digestive enzymes cannot break down dietary fibre — the complex carbohydrates found in vegetables, fruits, legumes, whole grains, nuts, and seeds. When undigested fibre reaches the large intestine, specialist bacteria equipped with the necessary fermentative enzymes break it down. The primary metabolic outputs of this fermentation are the short-chain fatty acids: primarily butyrate, acetate, and propionate, along with smaller amounts of valerate, caproate, and other organic acids.
This means SCFA production depends on two things simultaneously: the fibre input that provides the substrate, and the bacterial capacity that performs the fermentation. A diet high in diverse plant fibre, paired with a depleted microbiome, produces fewer SCFAs than the same diet paired with a diverse, butyrate-producing microbiome. A diverse microbiome, paired with a low-fibre diet, produces fewer SCFAs than the same microbiome fed diverse plant fibre. Both inputs matter — and this is the core logic behind the “soil and seed” principle. Read: The Gut Microbiome Explained →
Different types of fibre are fermented by different bacterial species. Inulin (from onions, garlic, chicory) feeds Bifidobacteria. Pectin (from apples, citrus) feeds different species. Beta-glucan (from oats and barley) feeds yet another set. Resistant starch (from legumes, cooled cooked potatoes) specifically feeds butyrate-producing Firmicutes including Faecalibacterium prausnitzii. Eating the same fibre source repeatedly sustains only the bacteria that ferment that fibre. Diverse fibre sources → diverse bacterial species sustained → diverse SCFA production profiles → maximum protective benefit. This is why 30+ different plant varieties per week is the target, not just “eat more fibre.” Read: 30 Plants Per Week →
The three principal SCFAs each play distinct roles and act in different locations. Understanding which does what clarifies why fibre diversity and microbiome health matter across such a wide range of health outcomes.
The gut guardian — ~15% of total SCFA production
Butyrate is the most important SCFA for local gut health. It is the primary energy source for colonocytes — the cells lining the colon — providing 60–70% of their energy requirements. Without adequate butyrate, colonocytes cannot divide and replace themselves at the normal rate, and the gut barrier weakens. Butyrate also maintains the tight junction proteins (the molecular “cement” between barrier cells), regulates intestinal immune cell function directly, soothes overreactive gut nerve endings (visceral hypersensitivity), and has epigenetic effects — switching on genes that suppress inflammation and switching off genes that promote it. Most of the butyrate produced in the colon is consumed locally by colonocytes; relatively little reaches the bloodstream. This is why local production — in the colon, from bacterial fermentation — is the only meaningful source. You cannot meaningfully supplement your way to adequate colonic butyrate without addressing the microbiome and fibre inputs that produce it there.
Primary producers: Faecalibacterium prausnitzii, Roseburia intestinalis, Eubacterium rectale, Butyricicoccus pullicaecorum — all require diverse fermentable fibre including resistant starch and inulin-type fructans.
The systemic signaller — ~60% of total SCFA production
Acetate is the most abundant SCFA by volume. Unlike butyrate, it is not primarily consumed by colonocytes — it passes into the bloodstream and reaches peripheral tissues including muscle, heart, brain, and liver. In the liver, acetate is a substrate for cholesterol synthesis regulation and energy metabolism. It acts on receptors throughout the body that regulate appetite, energy expenditure, and fat storage. Importantly, acetate also serves as a substrate for butyrate production by cross-feeding — some acetate produced by Bifidobacteria is consumed by butyrate producers including Roseburia, which use it to synthesise butyrate. This cross-feeding relationship means Bifidobacteria diversity (fed by inulin and GOS in legumes and onions) directly supports butyrate production — even though Bifidobacteria themselves do not make butyrate.
Primary producers: Bifidobacteria, Lactobacillus, Akkermansia muciniphila — fed by inulin, GOS, pectin, and diverse plant polyphenols.
The metabolic regulator — ~25% of total SCFA production
Propionate is transported to the liver, where it is a substrate for gluconeogenesis (glucose production) and inhibits cholesterol synthesis. It activates free fatty acid receptors (FFARs) in the gut lining that signal satiety — propionate is one of the mechanisms through which high-fibre diets reduce appetite and support healthy weight. It also has direct effects on liver inflammation and has been studied for its role in reducing non-alcoholic fatty liver disease risk. Propionate signals to the brain via the gut-brain axis to reduce food reward and cravings — a mechanism being explored in appetite regulation research.
Primary producers: Bacteroides thetaiotaomicron, Phascolarctobacterium, some Veillonella — fed by pectin, inulin, and diverse resistant starches.
The gut barrier is a single layer of epithelial cells lining the entire intestinal tract — a surface area roughly equivalent to a tennis court, folded into the colon. These cells are held together by protein complexes called tight junctions — molecular structures that seal the gaps between adjacent cells and control what passes from the gut lumen (the intestinal space) into the bloodstream. When tight junctions are intact, the barrier selectively allows nutrients to pass while blocking bacterial components, toxins, and undigested food particles.
Butyrate is the energy source that powers colonocyte function and drives the synthesis of the tight junction proteins themselves. The key proteins — claudins, occludins, and ZO-1 — that form these molecular seals are prepared from the energy provided by butyrate. Think of butyrate as the cement that holds the bricks of the wall together. Without adequate butyrate, colonocytes do not have the energy to maintain tight junctions, barrier cells do not replicate quickly enough to keep the wall intact, and the barrier gradually becomes more permeable.
When the barrier becomes permeable — what is clinically described as increased intestinal permeability, and colloquially as “leaky gut” — bacterial endotoxin (LPS, lipopolysaccharide) from the coating of gram-negative bacteria in the gut crosses into the bloodstream. The immune system, which has been evolutionarily trained to treat LPS as an urgent threat signal indicating bacterial invasion, activates in response. But because this leakage is low-grade and continuous rather than a discrete acute infection, the immune response is also low-grade and continuous — the hallmark of chronic low-grade inflammation. Read: What Is Gut Dysbiosis? →
The gut epithelial barrier completely renews every 3–5 days. Colonocytes are among the fastest-dividing cells in the body. This means that when adequate butyrate becomes available — through improved fibre intake and microbiome rebuilding — barrier repair begins within days. The body’s capacity for rapid recovery is genuinely remarkable: the infrastructure that enables it just needs the butyrate fuel supply to be restored.
Beyond tight junctions, the gut barrier is protected by a mucus layer — a thick gel secreted by goblet cells that physically separates the bacterial community from the epithelial surface. Butyrate and acetate stimulate goblet cell function and mucus production. Akkermansia muciniphila, a keystone species in gut health, lives within and feeds on this mucus layer, maintaining its thickness and structural integrity. Akkermansia abundance is consistently lower in dysbiotic microbiomes with IBS.
Butyrate supplements (sodium butyrate, butyrate enemas) are sometimes prescribed clinically. However, orally consumed butyrate is largely absorbed in the small intestine before reaching the colon where it is needed. The only way to reliably raise colonic butyrate levels is to provide the fibre substrate that gut bacteria ferment locally to produce it. This is why the dietary and microbiome approach — not supplementation — is the evidence-based path to restored SCFA production.
Visceral hypersensitivity — the overreaction of gut nerve endings to stimuli that would not cause pain in a healthy gut — is one of the defining mechanisms of IBS. It is what causes the same amount of normal colonic distension that a person without IBS barely notices to produce significant pain in someone with IBS. The underlying mechanism is overactivation of the 500 million nerve endings lining the gut wall — a sensitisation produced and maintained by insufficient butyrate production.
Butyrate has a direct, documented soothing effect on these gut nerve endings. The mechanism operates through several pathways:
Butyrate directly modulates the activity of pain-sensing neurons (nociceptors) in the gut wall by binding to free fatty acid receptors (FFAR2/FFAR3) expressed on enteric neurons. This binding reduces neuronal excitability — essentially turning down the volume on the pain signal. In a microbiome with adequate butyrate-producing bacteria, this regulatory process keeps gut nerve sensitivity at a normal, manageable baseline. When butyrate production is depleted, this natural damping mechanism is lost, and the nerves remain in a state of chronic over-activation.
Butyrate inhibits NF-κB — the master transcription factor that switches on inflammatory gene expression in gut mucosal cells. When butyrate is present in adequate amounts, NF-κB activity is suppressed, inflammatory cytokine production is reduced, and mucosal inflammation is kept at baseline. When butyrate is depleted, this suppression is lost: mucosal inflammation increases, sensitising the same nerve endings that butyrate was suppressing through the nociceptor pathway. Visceral hypersensitivity is therefore driven by both pathways simultaneously — reduced direct nerve calming AND increased inflammation amplifying sensitivity.
Butyrate is a histone deacetylase (HDAC) inhibitor — meaning it influences gene expression by modifying the histone proteins around which DNA is wrapped. This epigenetic action allows butyrate to switch off pro-inflammatory gene programs and switch on anti-inflammatory and barrier-repair gene programs. These effects operate in the gut mucosa and — because some butyrate reaches the bloodstream — in peripheral tissues including the brain, where they contribute to neuroprotective effects and reduced neuroinflammation.
A practising gastroenterologist who has treated IBS for over a decade describes this directly: when asked what the natural way to reduce gut sensitivity is, the answer is butyrate — produced by gut bacteria from dietary fibre. Not antispasmodics, not pain medication, not endlessly eliminating foods. The soothing of gut nerve sensitisation is a natural biological process powered by adequate butyrate production. Restoring that production through fibre diversity and microbiome rebuilding is the mechanism by which IBS symptoms improve over months — not just being managed. Read: What Is IBS? → and How to Reduce Bloating →
70% of the immune system lives in the lining of the gut — and SCFAs are the primary regulators of how that immune system behaves. The distinction between a well-calibrated immune system and a chronically over-activated one comes down, in large part, to adequate SCFA production.
SCFAs modulate immune function through multiple mechanisms. They act as ligands for G-protein-coupled receptors (GPCRs) on immune cells — particularly FFAR2 and FFAR3 — activating anti-inflammatory signalling cascades and suppressing pro-inflammatory ones. They inhibit NF-κB activity in macrophages and dendritic cells, reducing the production of inflammatory cytokines including TNF-α, IL-6, and IL-1β. They promote the differentiation of regulatory T cells (Tregs) — the immune cells specifically tasked with preventing over-activation and autoimmunity. And they directly reduce the production of reactive oxygen species (free radicals) that drive oxidative stress.
The net effect of adequate SCFA production is an immune system that is strong, precise, and targeted: activated strongly when it needs to be (during genuine infection or injury), but calibrated to stay in a resting baseline state otherwise. The net effect of SCFA depletion — from dysbiosis and fibre deficiency — is the opposite: an immune system that is persistently, low-grade activated, producing chronic inflammation that is not resolving because there is no resolution signal from SCFAs. This is the biochemical mechanism connecting what you eat to whether you have chronic low-grade inflammation. Read: What Is Chronic Inflammation? →
Health conditions now associated with chronic inflammation — from IBS and depression to cardiovascular disease, type 2 diabetes, and Alzheimer’s. All trace back to the same inadequate SCFA production driving immune dysregulation.
Specific blood inflammatory proteins reduced in the Stanford FIFI study through increased fermented food intake — the same pathway as restoring SCFA-producing bacterial diversity through fibre and fermented food consumption working together.
Inflammation level is twice as important as cholesterol level for predicting long-term health outcomes — per research cited in leading gastroenterology work. SCFA production is the primary dietary regulator of that inflammation level.
The influence of SCFAs extends beyond the gut and immune system into the central nervous system — and this is where the connection between gut health and mental health becomes biochemically tangible.
Neuroinflammation — inflammation within the brain — is now identified as the common thread linking major depression, Parkinson’s disease, and Alzheimer’s disease. It is caused by the same pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) that SCFA depletion fails to suppress in the immune system. These cytokines cross the blood-brain barrier or activate microglia (the brain’s resident immune cells) to produce neuroinflammatory responses that disrupt neurotransmitter function, impair neuronal repair, and degrade cognitive capacity.
SCFAs act against neuroinflammation through three documented pathways. First, by reducing systemic inflammation (the anti-inflammatory mechanisms described in the previous section), they reduce the pool of inflammatory signals available to cross into the brain. Second, butyrate that reaches the bloodstream can cross the blood-brain barrier directly, where its HDAC-inhibiting properties suppress neuroinflammatory gene programmes in microglia. Third, acetate and propionate act on hypothalamic neurons that regulate appetite, mood, and stress responses — contributing to the appetite-satiating and mood-stabilising effects associated with high-fibre, high-SCFA diets.
This is why the 50% co-occurrence of depression and anxiety with IBS is not coincidental and not primarily psychological. When the microbiome is dysbiotic and SCFA production is depleted, both gut symptoms and mood disruption trace back to the same source. Healing the microbiome and restoring SCFA production addresses both. Read: The Gut-Brain Axis →
One of the most practically useful findings in SCFA research is what might be called the polyphenol amplifier effect — and it has significant implications for how to approach the diet.
Polyphenols are the pigment compounds responsible for the colours in plant foods — the red in raspberries, the purple in aubergine, the orange in turmeric, the dark green in kale. There are at least 8,000 identified polyphenols in food, and 90–95% of them require gut bacteria to unlock their bioactive forms. They are too large and complex to be absorbed directly in the small intestine; they travel to the colon where specialist bacterial enzymes metabolise them into their active forms, which then enter circulation and confer their anti-inflammatory and anti-aging effects.
Here is the amplifier effect: when you add polyphenols to the same amount of dietary fibre — without changing the fibre quantity — the gut microbiome produces more short-chain fatty acids from that same fibre. Polyphenols do not directly become SCFAs, but their interaction with the gut microbiome shifts the microbial community in a direction that is more metabolically productive, generating higher SCFA output from the available fibre substrate.
The practical implication is powerful: eating colourful, polyphenol-rich plants alongside fibre-rich plants does not just add the polyphenol benefit. It multiplies the SCFA benefit from the fibre already present. A bowl of lentils (fibre, GOS) with a handful of colourful vegetables (polyphenols) plus a pinch of turmeric and black pepper (more polyphenols) produces more butyrate than the same lentils eaten alone. The rainbow does not just find the pot of gold — it increases the size of the pot. Read: 30 Plants Per Week → and How to Eat for Gut Health →
Every time you add a new colour to your plate — a sprinkling of turmeric, a handful of blueberries, a side of red cabbage sauerkraut, a squeeze of lemon — you are not just adding a polyphenol. You are amplifying the SCFA production from every gram of fibre already in that meal. The synergy between fibre and polyphenols means that a diverse, colourful plate produces significantly more butyrate, acetate, and propionate than a nutritionally equivalent meal with the same caloric content but fewer plant varieties. This is why plant diversity matters more than simple fibre quantity — and why the 30-plant target is about the combination of fibre and polyphenol variety together.
Understanding SCFAs reframes what fibre deficiency actually means. It is not simply a matter of insufficient roughage — of not eating enough vegetables. Fibre deficiency is a SCFA production deficiency. And given what SCFAs do — maintain the gut barrier, regulate immunity, calm visceral hypersensitivity, protect against neuroinflammation — fibre deficiency is a systemic health deficiency with consequences reaching far beyond the gut.
The scale of the problem is staggering. Approximately 95% of Americans and 90% of people in the UK consume less fibre than is needed for optimal gut microbiome function. The Professor Andrew Reynolds meta-analysis — one of the most rigorous nutritional studies ever conducted — demonstrated that higher dietary fibre is associated with reduced risk of heart disease, heart attack, three forms of cancer (breast, colorectal, and oesophageal), stroke, and type 2 diabetes. Every single one of these conditions is now understood to involve chronic low-grade inflammation — the same inflammation that depleted SCFA production from fibre-deficient diets fails to suppress.
This is not a coincidence. It is a causal chain: fibre deficiency → depleted SCFA production → weakened gut barrier → LPS leakage → chronic immune activation → chronic inflammation → downstream chronic disease. The fibre conversation — far from being a mundane nutritional talking point about digestive health — is a conversation about the central biochemical mechanism behind the most prevalent chronic diseases of the industrialised world.
Everything else in the gut health recovery protocol ultimately comes back to SCFAs. Increasing fibre diversity feeds the bacteria that produce them. Fermented foods seed the gut with more butyrate-producing species. Reducing ultra-processed food removes the compounds that damage the bacterial community that makes them. Consistent sleep and stress regulation maintain the microbial ecosystem that produces them. Here is the direct SCFA production protocol.
These are the fibre types with the strongest evidence for supporting butyrate-producing bacterial species specifically — not just general fibre intake:
| Fibre type | Best food sources | Primary SCFA supported |
|---|---|---|
| Resistant starch | Legumes (lentils, chickpeas, beans), cooled cooked potatoes and rice, green bananas, oats | Butyrate (most direct) |
| Inulin / fructans | Onions, garlic, leeks, asparagus, chicory root, Jerusalem artichoke, rye | Acetate (via Bifidobacteria) → cross-fed to butyrate |
| Beta-glucan | Oats, barley, rye, some mushrooms | Butyrate and propionate |
| GOS (galacto-oligosaccharides) | Legumes (lentils, chickpeas, kidney beans, edamame), cashews, pistachios | Acetate → butyrate (cross-feeding) |
| Pectin | Apples, pears, citrus (especially the white pith), berries, carrots | Propionate and acetate |
| Arabinoxylan | Wheat bran, rye, psyllium husk | Butyrate and propionate |
| Diverse mixed fibres | Seeds (chia, flax, hemp), leafy greens, diverse vegetables | All three SCFAs — diversity drives total output |
The ecosystem that produces SCFAs — understanding the full microbiome picture.
The disruption that depletes SCFA production — causes, mechanisms, and the cascade toward disease.
How to build the dietary diversity that maximises SCFA production — the practical guide.
How to build the fibre intake that drives butyrate production — at a pace the IBS gut can tolerate.
🔥 What Is Chronic Inflammation? → — how SCFA depletion drives the 130+ condition inflammatory cascade
🧠 What Is IBS? → — why visceral hypersensitivity is the natural consequence of SCFA depletion
💨 How to Reduce Bloating → — butyrate as the natural bloating relief mechanism
🥦 How to Eat for Gut Health → — the complete dietary framework for SCFA optimisation
The evidence for oral butyrate supplements is limited for a fundamental reason: oral butyrate is largely absorbed in the small intestine before it reaches the colon where it is needed. The small fraction that makes it to the colon is far less than what a healthy gut microbiome produces locally from dietary fibre. Sodium butyrate and butyrate enemas have clinical applications in specific conditions (particularly in IBD management), but for general gut health and IBS, dietary fibre diversity and microbiome rebuilding are far more effective approaches to restoring colonic butyrate levels. The research consistently supports feeding the bacteria that make butyrate rather than attempting to deliver it externally.
Both effects are real and are not contradictory — they just operate on different timescales. Legumes are rich in GOS (galacto-oligosaccharides) and resistant starch, which are among the most potent fermentable substrates for butyrate production. In a gut with an established population of butyrate-producing bacteria, this fermentation is relatively efficient and the gas produced is manageable. In a depleted microbiome — as in many people with IBS — the fermentation is less efficient and proportionally more gas is produced relative to butyrate. The solution is progressive introduction: starting with 2–3 tablespoons of canned legumes (well rinsed) and increasing by a tablespoon per week, giving the microbiome time to expand the bacterial populations that ferment legumes more cleanly into butyrate. Within weeks of consistent small-portion legume consumption, most people find their tolerance increases measurably as the relevant butyrate producers grow in number.
The gut barrier — whose integrity depends on adequate butyrate — renews every 3–5 days, so barrier improvement can begin within a week of significant dietary changes. Measurable reductions in visceral hypersensitivity — felt as reduced bloating severity and improved pain tolerance to normal fermentation — typically emerge over 4–8 weeks of consistent high-fibre, diverse plant eating alongside microbiome rebuilding with fermented foods. The Stanford FIFI study measured inflammatory protein reductions over 10–12 weeks. Deep changes to microbiome composition and butyrate-producing bacterial population density take 3–6 months of consistent protocol adherence. But the direction of change is measurable and felt far sooner than the 6-month endpoint.
No — and in some cases cooking and then cooling actually increases it. Cooking softens plant cell walls and makes fibre more accessible to gut bacteria. Cooling cooked starchy foods (potatoes, rice, legumes) causes the starch to retrograde into resistant starch — a form that is not digested in the small intestine and reaches the colon intact, where it is one of the most effective butyrate-producing substrates available. This is why yesterday’s cold potato salad produces more butyrate than freshly cooked hot potato. Vegetables lose some water-soluble nutrients during boiling but their fibre content and SCFA potential remains largely intact regardless of cooking method. For maximum polyphenol and nutrient retention alongside fibre, steaming and roasting preserve more micronutrients than boiling in water.
Track your weekly plant count alongside your gut symptoms and watch the correlation build. The data shows the butyrate story playing out in real time.
Or open the daily tracker to log symptoms and see your gut health improving week by week →
Medical Disclaimer: The content on GoGoMicrobiome is for educational purposes only and does not constitute medical advice. Please consult a qualified healthcare professional before making significant dietary changes, particularly if you have IBS, IBD, or other gut conditions. See our full disclaimer.